Takeda Targets Dr. Reddy's Over Generic Dexilant

By Allison Grande · April 4, 2011, 3:07 PM EDT

Takeda Pharmaceutical Co. Ltd. launched a patent infringement suit Friday in New York over Dr. Reddy's Laboratories Ltd.'s efforts to manufacture a generic version of acid reflux treatment Dexilant....

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

Takeda Pharmaceutical Co., Ltd. et al v. Dr. Reddy's Laboratories, Ltd. et al

Case Number

Court

New York Southern

Nature of Suit

Patent

Date Filed

April 01, 2011

Recent Articles By Allison

March 31, 2025
FTC Chair Flags Data Risks In 23andMe Bankruptcy
March 20, 2025
Atrium Health Escapes Privacy Suit Over Meta Data Sharing
March 07, 2025
Orlando Health Can't Duck Suit Over Sharing Of Patients' Data
March 06, 2025
Apria Healthcare To Pay $6.4M To End Data Breach Litigation
February 11, 2025
Wash. Health Privacy Law Debuts In Amazon Tracking Suit
January 27, 2025
UnitedHealth Raises Cyberattack Estimate To 190M Individuals
December 20, 2024
Top Privacy & Cybersecurity Developments Of 2024
October 29, 2024
NY Health Provider To Boost Data Security To End AG's Probe
October 16, 2024
BetterHelp Can't Ax Suit Over Sharing Data With Advertisers
October 01, 2024
Jefferson Health Can't Ditch Suit Over Meta Data Sharing